Old West Investment Management LLC bought a new stake in Cabot Corporation (NYSE:CBT – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 12,326 shares of the specialty chemicals company’s stock, valued at approximately $1,119,000.
Several other hedge funds and other institutional investors have also bought and sold shares of CBT. Global Retirement Partners LLC bought a new position in Cabot in the 2nd quarter valued at $88,000. 1ST Source Bank purchased a new position in shares of Cabot in the 2nd quarter worth about $1,011,000. Bank of New York Mellon Corp bought a new position in Cabot during the second quarter valued at about $57,445,000. State of Wyoming purchased a new stake in Cabot during the second quarter worth about $345,000. Finally, Oppenheimer Asset Management Inc. bought a new stake in Cabot in the second quarter worth about $4,528,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on CBT. UBS Group dropped their target price on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 5th. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Mizuho upped their price target on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Tuesday, May 26th. Finally, Truist Financial set a $100.00 price objective on shares of Cabot in a research report on Wednesday, August 5th. Two research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $89.00.
Cabot Trading Down 0.1%
Cabot stock opened at $87.82 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $94.53. The stock has a market cap of $4.53 billion, a P/E ratio of 24.74, a PEG ratio of 11.47 and a beta of 0.84. The firm’s fifty day moving average price is $88.12 and its 200-day moving average price is $80.46.
Cabot (NYSE:CBT – Get Free Report) last posted its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. During the same quarter last year, the company earned $1.90 earnings per share. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities research analysts forecast that Cabot Corporation will post 6.33 earnings per share for the current fiscal year.
Cabot Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be issued a $0.4725 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 annualized dividend and a dividend yield of 2.2%. Cabot’s dividend payout ratio (DPR) is presently 53.24%.
Insider Activity
In other news, CEO Sean D. Keohane sold 91,923 shares of Cabot stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $86.41, for a total transaction of $7,943,066.43. Following the completion of the sale, the chief executive officer owned 404,134 shares in the company, valued at approximately $34,921,218.94. This trade represents a 18.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 3.08% of the company’s stock.
Cabot Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Read More
- Five stocks we like better than Cabot
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
